ArticleCancer research and treatment2022
Fear of Cancer Recurrence and Its Negative Impact on Health-Related Quality of Life in Long-term Breast Cancer Survivors.
Article in Cancer research and treatment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
51 citing papers in PubMed, 5 syntheses or guidelines pooled it, 80 citations in OpenAlex.
- [Integrated care for long-responder women with metastatic breast cancer: Expert opinion for long term management in spain].Atencion primaria · 2026Guideline
- Comparison of the effects of cognitive-supportive-relaxation multimodal psychosocial intervention on fear of cancer recurrence and psychological resilience in breast cancer patients: a network meta-analysis based on randomized controlled trials.Frontiers in oncology · 2026Pooled it
- Family Involvement Interventions on Fear of Cancer Recurrence Management Among Women With Breast Cancer and Their Caregivers: A Systematic Review and Meta-Analysis.Journal of clinical nursing · 2025Pooled it
- Psychosocial factors associated with quality of life in cancer survivors: umbrella review.Journal of cancer research and clinical oncology · 2024Pooled it
- Immediate impact of Mindfulness-Based Cognitive Therapy (MBCT) among women with breast cancer: a systematic review and meta-analysis.BMC women's health · 2023Pooled it
- Effects of acceptance and commitment therapy on fear of progression in young and middle-aged patients with breast cancer receiving particle therapy: a randomized controlled trial.Frontiers in public health · 2026Trial
- Quality of life and patient reported outcomes in the UK Mammo-50 randomised trial of annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and over.Health and quality of life outcomes · 2025Trial
- Fear of Cancer Recurrence and Associated Factors Among Women with Female Cancer: A Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2026Article
- Fear of Cancer Recurrence and Psychological Symptom Burden in Breast Cancer Survivors Without Evidence of Active Disease: A Cross-Sectional Real-World Study.Healthcare (Basel, Switzerland) · 2026Article
- Exploring the Social and Stigma-Related Lived Experiences of Pediatric Cancer Survivors in a Canadian Province.Current oncology (Toronto, Ont.) · 2026Article
- Factors influencing fear of cancer recurrence in breast cancer survivors: a multicenter cross-sectional study.BMC women's health · 2026Article
- Association Between Maladaptive Cognitive Emotion Regulation and Fear of Cancer Recurrence in Breast Cancer Patients With a History of Suicide Attempts: A Cross-Sectional Study.Cancer medicine · 2026Article
- Interventions to Reduce Fear of Cancer Recurrence Among People With Cancer: Scoping Review.JMIR cancer · 2026Article
- Novel antibody cocktail therapy targeting extracellular tumor-specific mutations to treat EMT6 cell line-derived triple-negative breast cancer.Scientific reports · 2026Article
- Dyadic family hardiness and coping styles on fear of cancer recurrence in adolescent malignant bone tumor patients and caregivers.Scientific reports · 2026Article
- Relationships Between Fear of Cancer Recurrence, Unmet Healthcare Needs, and Quality of Life Among Thai Breast Cancer Survivors Post-Treatment.Healthcare (Basel, Switzerland) · 2026Article
- Body image distress, self-esteem, and psychological adjustment following breast cancer surgery: a comparative and mediation analysis.Health psychology and behavioral medicine · 2026Article
- Associations between fear of cancer recurrence and post-traumatic growth in patients with primary liver cancer: a latent profile analysis and mediation analysis.Frontiers in psychiatry · 2026Article
- Quality of life of breast cancer patients: A comparative study of survivors and patients undergoing radiotherapy in Morocco.Journal of education and health promotion · 2026Article
- Fear of cancer recurrence among young breast cancer patients: a qualitative study guided by social ecological systems theory.Frontiers in psychology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 3 institutions in 1 country.
Funding
Abstract
purposeFear of cancer recurrence (FCR) is a common psychological issue in breast cancer (BC) survivors during early survivorship but whether the same is true among long-term survivors has yet to be empirically evaluated. This study investigated FCR level, its associated factors, and impact on quality of life (QoL) in long-term BC survivors. MATERIALS AND
methodsParticipants included women diagnosed with BC between 2004 and 2010 at two tertiary hospitals. Survey was conducted in 2020. The study measured FCR with the Fear of Cancer Recurrence Inventory and other patient-reported outcomes, including depression and cancer-related QoL. Logistic regression was used to identify factors associated with FCR, and structural equation modeling was conducted to explore the impact of FCR on other outcomes.
resultsOf 333 participants, the mean age at diagnosis was 45.5, and 46% experienced FCR. Age at diagnosis ≤ 45 (adjusted odds ratio [aOR], 2.64; 95% confidence interval [CI], 1.51 to 4.60), shorter time since diagnosis (aOR, 1.75, 95% CI, 1.08 to 2.89), and having a history of recurrence (aOR, 2.56; 95% CI, 1.16 to 5.65) was associated with more FCR. FCR was significantly associated with an increased risk of depression (β=0.471, p < 0.001) and negatively impacted emotional functioning (β=-0.531, p < 0.001). In addition, a higher FCR level may impair overall health-related QoL in long-term BC survivors (β=-0.108, p=0.021).
conclusionTen years after diagnosis, long-term BC survivors still experienced a high level of FCR. Further, the negative impact of FCR on QoL and increased depression risk require an FCR screening and appropriate interventions to enhance long-term BC survivors' QoL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.